Funding for this research was provided by:
Ministero della Salute (ricerca corrente)
Received: 8 January 2020
Accepted: 26 January 2020
First Online: 3 February 2020
Ethics approval and consent to participate
: The study has been approved by Ethic Committee as a part of the Ricerca Corrente project entitled: “Trattamento del Non Small Cell Lung Cancer (NSCLC) in stadio avanzato modulato sul profilo farmaco-genomico individuale”.
: Patients evaluated in the study were enrolled in the above-mentioned protocol and signed informed consent.
: CB is consultant for Bracco Imaging Italia and Doc. Congress. The authors declare that they have no competing interests.